Twitter Facebook LinkedIn YouTube

Imagin Medical (CSE: IME) Announced a Non-Brokered Private Placement

Video Platform Video Management Video Solutions Video Player

Proceeds will be used for general working capital, and advancing the development of imaging solutions for minimally invasive surgical procedures where endoscopes are used for the early detection of cancer.

Additional Information:

Company: Imagin Medical
Website: http://www.imaginmedical.com
Stock Symbol: CSE: IME
Date Published: Sep 27, 2017
Transcript: Available

Video Transcript:

I’m Samantha Deutscher for Investmentpitch Media

Imagin Medical, a medical imaging company, has announced a non-brokered private placement.

The company plans to raise gross proceeds of up to $600,000 from the issuance of up to 12 million units, priced at $0.05 per unit, with each unit consisting of 1 share and 1 warrant.

The warrants are exercisable at $0.10 for 12 months.

Proceeds will be used for general working capital, and advancing the development of imaging solutions for minimally invasive surgical procedures where endoscopes are used for the early detection of cancer.

The ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors.

The company believes it will radically improve the way physicians detect cancer and view the surgical field.

Imagin’s initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a greater than 50% recurrence rate.

The shares are trading at $0.10 and with 50.1 million shares outstanding, the company is capitalized at $5 million.

For more information please visit the company’s website www.imaginmedical.com, contact Jim Hutchens, President and CEO, at 617-571-6006 or email jhutchens@imaginmedical.com.

I’m Samantha Deutscher for Investmentpitch Media